RxDoctor Payments Data

Kelly Konopa, MD

Hematology & Oncology · Salt Lake City, UTNPI 1033272489

Payments from drug & device makers

$207in general payments, 2019–2025

Across 13 payments — averaging $15.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$48
  • AstraZeneca$39
  • Johnson & Johnson$37
  • Gilead$25
  • Agios Pharmaceuticals, Inc.$16
  • Servier Pharmaceuticals LLC$15
  • plus $27 from 2 others

What the payments were for

  • Food & beverage$207100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$207 in reported general payments places this provider in the 10th percentile of 77 hematology & oncology providers in Utah.

See all hematology & oncology providers in Utah

Medicare billing

Part B allowed, 2024
$8,755
Medicare patients
18
Services billed
126

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →